Yonsei Med J.  2007 Apr;48(2):192-200. 10.3349/ymj.2007.48.2.192.

Associations between Smoking, Screening, and Death Caused by Cervical Cancer in Korean Women

• Odongua N
• Chae YM
• Kim MR
• Yun JE
• Jee SH

• KMID: 1779520
• DOI: http://doi.org/10.3349/ymj.2007.48.2.192

Abstract

PURPOSE
Cervical cancer is a major women's health problem in the world today. The purpose of this study was to estimate the incidence and mortality rates and to investigate risk factors for cervical cancer in Korean women. MATERIALS AND METHODS: Reproductive factors, cigarette smoking, as well as the risk of incidence and death from cervical cancer were examined in a 12-year prospective cohort study of 475,398 Korean women aged 30 to 95 years who received health insurance from the National Health Insurance Corporation and who had a medical evaluation in 1992. Relative risks (RR) and 95% confidence intervals (CI) were calculated using the Cox proportional hazards model after adjusting for age, body mass index, cigarette smoking, alcohol use, menarche, parity, and Papanicolaou test status. RESULTS: This study showed that the RR of death due to cervical cancer among current smokers was two times higher compared with non- smokers (RR=2.00; 95% CI, 1.23-2.91). In addition, the RR of death due to cervical cancer among all women who smoked > 10 cigarettes/day was 2.4 times higher than the RR among women that had never smoked. More interestingly, those who had never been screened by Papanicolaou smears had twice the risk of death due to cervical cancer (RR =2.00; 95% CI, 1.37-1.81). CONCLUSION: Our prospective study concluded that current smokers had an increased risk of death due to cervical cancer. We suggest that the target age group for cervical cancer screening tests be reconsidered and should begin as early as possible.

Keyword

Cervical cancer; risk factors; smoking; screening papanicolaou smears; cohort study

Figure

• 

  Fig. 1 Age-adjusted standard incidence and mortality rates among all women by age group.

Reference

1. Elkas J, Farias-Eisner R. Cancer of the uterine cervix. Curr Opin Obstet Gynecol. 1998. 10:47–50.

2. Cole HM. Women's health on the Web. JAMA. 1999. 282:1211–1212.

3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005. 55:74–108.

4. Jung WW, Chun T, Sul D, Hwang KW, Kang HS, Lee DJ, et al. Strategies against human papillomavirus infection and cervical cancer. J Microbiol. 2004. 42:255–266.

5. Kim IS, Suh I, Oh HC, Kim BS, Lee Y. Incidence and survival of cancer in Kanghwa County (1983-1987). Yonsei Med J. 1989. 30:256–268.

6. Shin HR, Ahn YO, Bae JM, Shin MH, Lee DH, Lee CW, et al. Cancer Incidence in Korea. Cancer Res Treat. 2002. 34:405–408.

7. Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med. 2002. 252:206–224.

8. Beral V, Hermon C, Munoz N, Devesa SS. Cervical cancer. Cancer Surv. 1994. 19-20:265–285.

9. Weiderpass E, Ye W, Tamimi R, Trichopolous D, Nyren O, Vainio H, et al. Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva. Cancer Epidemiol Biomarkers Prev. 2001. 10:899–901.

10. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA. 2003. 290:1739–1748.

11. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA. 2005. 293:194–202.

12. Kaneko S, Tamakoshi A, Ohno Y, Mizoue T, Yoshimura T; JACC Study Group. Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control. 2003. 14:53–59.

13. Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, Crossley B, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer. 2003. 89:2078–2086.

14. Hinkula M, Pukkala E, Kyyronen P, Laukkanen P, Koskela P, Paavonen J, et al. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Br J Cancer. 2004. 90:1025–1029.

15. Geerlings MI, Ruitenberg A, Witteman JC, van Swieten JC, Hofman A, van Duijn CM, et al. Reproductive period and risk of dementia in postmenopausal women. JAMA. 2001. 285:1475–1481.

16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004. 363:157–163.

17. Brinton LA, Hamman RF, Huggins GR, Lehman HF, Levine RS, Mallin K, et al. Sexual and reproductive risk factors for invasive squamous cell cervical cancer. J Natl Cancer Inst. 1987. 79:23–30.

18. Herrero R, Brinton LA, Reeves WC, Brenes MM, Tenorio F, de Britton RC, et al. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population. Cancer. 1990. 65:380–386.

19. Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst. 1986. 76:423–428.

20. Eluf-Neto J, Booth M, Munoz N, Bosch FX, Meijer CJ, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer. 1994. 69:114–119.

21. Sriamporn S, Parkin DM, Pisani P, Suwanrungruang K, Pengsaa P. Behavioural risk factors for cervical cancer from a prospective study in Khon Kaen, Northeast Thailand. Cancer Detect Prev. 2004. 28:334–339.

22. Misra JS, Gupta HP, Das V. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening. Diagn Cytopathol. 2004. 31:376–379.

23. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004. 364:249–256.

24. Baldwin P, Laskey R, Coleman N. Translational approaches to improving cervical screening. Nat Rev Cancer. 2003. 3:217–226.

25. Schoell WM, Janicek MF, Mirhashemi R. Epidemiology and biology of cervical cancer. Semin Surg Oncol. 1999. 16:203–211.

26. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002. 52:342–362.

27. Force USPST. Guide to Clinical Preventive Services. 1996. 2nd. Alexandria, VA: International Medical Publishing.

28. Coker AL, Rosenberg AJ, McCann MF, Hulka BS. Active and passive cigarette smoke exposure and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1992. 1:349–356.

29. Trevathan E, Layde P, Webster LA, Adams JB, Benigno BB, Ory H. Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix. JAMA. 1983. 250:499–502.

30. Tay SK, Tay KJ. Passive cigarette smoking is a risk factor in cervical neoplasia. Gynecol Oncol. 2004. 93:116–120.

31. Trimble CL, Genkinger JM, Burke AE, Hoffman SC, Helzlsouer KJ, Diener-West M, et al. Active and passive cigarette smoking and the risk of cervical neoplasia. Obstet Gynecol. 2005. 105:174–181.

32. Slattery ML, Robison LM, Schuman KL, French TK, Abbott TM, Overall JC Jr, et al. Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer. JAMA. 1989. 261:1593–1598.

33. Prokopczyk B, Cox JE, Hoffmann D, Waggoner SE. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst. 1997. 89:868–873.